SLS Latest Headlines

SELLAS (SLS): Advancing AML Pipeline, Strengthened Balance Sheet, and Upcoming Catalysts Drive Higher Target and Buy Rating

at www.tipranks.com (Sat, 14-Mar 1:45 AM)

Enrollment Milestone for SLS009: Phase 2 AML Trial Targets Patients Least Likely to Respond to Standard Therapy

Market Chameleon (Thu, 12-Mar 9:25 AM)

SELLAS Strengthens Capital Base Through Warrant Exercises

at www.tipranks.com (Wed, 11-Mar 9:34 PM)

Survival Events in SLS REGAL Trial Lag Expectations—Potentially Positive Sign for AML Therapy Outcomes

Market Chameleon (Tue, 30-Dec 10:29 AM)

SLS Faces Key Milestone as Phase 3 REGAL Trial Nears Final Analysis with Delayed Event Count

Market Chameleon (Mon, 29-Dec 11:44 AM)